Thiopurines are known to cause lymphopenia (<1,500 lymphocytes/μl). As severe lymphopenia (<500C/μl) is associated with opportunistic infections, we investigated severity of thiopurine-related lymphopenia and development of opportunistic infections in our tertiary referral centre.We retrospectively screened medical records of 1,070 IBD patients and identified 100 individuals that developed a total of 161 episodes of lymphopenia during thiopurine treatment between 2002 and 2014. Occurrence of opportunistic infections was documented. A control group consisted of IBD patients receiving thiopurines but without developing lymphopenia.Of a total of 161 episodes of lymphopenia, 23% were severe (<500C/μl). In this subgroup, thiopurine dosing was mo...
Background: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents...
Background: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents...
BACKGROUND: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents...
BACKGROUND Thiopurines are known to cause lymphopenia (<1,500 lymphocytes/μl). As severe lymphopenia...
Background & Aims: Thiopurine therapy for inflammatory bowel disease (IBD) has been associated with ...
International audienceBACKGROUND: Reports of an increased risk of lymphoproliferative disorders in p...
Background: Leucopenia is a common side effect in patients treated with thiopurines. Variants in the...
Introduction: Systemic inflammatory diseases are related to an increased risk of lymphoproliferative...
Increased risks of lymphoma and skin cancer associated with thiopurine use among patients with infla...
International audienceThe risk of lymphoproliferative disorders (LDs) has become a major concern for...
P>BackgroundSeveral reports suggest an increased rate of adverse reactions to azathioprine in pat...
BACKGROUNDS: The thiopurine drugs, azathioprine (AZA), and 6-mercaptopurine (6-MP) are well-establis...
Background: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents...
Background: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents...
BACKGROUND: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents...
BACKGROUND Thiopurines are known to cause lymphopenia (<1,500 lymphocytes/μl). As severe lymphopenia...
Background & Aims: Thiopurine therapy for inflammatory bowel disease (IBD) has been associated with ...
International audienceBACKGROUND: Reports of an increased risk of lymphoproliferative disorders in p...
Background: Leucopenia is a common side effect in patients treated with thiopurines. Variants in the...
Introduction: Systemic inflammatory diseases are related to an increased risk of lymphoproliferative...
Increased risks of lymphoma and skin cancer associated with thiopurine use among patients with infla...
International audienceThe risk of lymphoproliferative disorders (LDs) has become a major concern for...
P>BackgroundSeveral reports suggest an increased rate of adverse reactions to azathioprine in pat...
BACKGROUNDS: The thiopurine drugs, azathioprine (AZA), and 6-mercaptopurine (6-MP) are well-establis...
Background: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents...
Background: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents...
BACKGROUND: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents...